欧盟成员国授权药品清单_药药网

文档标题：活性物质：参考号：

国家授权药品清单1755个记录(本栏目收费,不能显示细节,电话13136136841)

"国家授权药品清单

序号

文档标题

活性物质

欧盟产品号

1754

Tapentadol: List of nationally authorised medicinal products - PSUSA/00002849/201411,

EMA/448789/2015

1753

Tamoxifen: List of nationally authorised medicinal products - PSUSA/00002846/201504,

1752

Trimetazidine: List of nationally authorised medicinal products - EMEA/H/N/PSR/J/0002,

EMA/637689/2016

1751

Trimetazidine: List of nationally authorised medicinal products - EMEA/H/N/PSR/0001,

EMA/283098/2016

1750

Trimetazidine: CMDh scientific conclusions, amendments to product information and implementation timetable - EMEA/H/N/PSR/0001 and EMEA/H/N/PSR/J/0002,

EMA/283107/2016

1749

Glipizide: List of nationally authorised medicinal products - PSUSA/00001535/201601,

EMA/639604/2016

1748

Glycopyrronium bromide (all indications except for chronic obstructive pulmonary disease): List of nationally authorised medicinal products - PSUSA/00001556/201509,

glycopyrronium bromide

EMA/474049/2016

1747

Glycopyrronium / neostigmine: List of nationally authorised medicinal products - PSUSA/00001557/201509,

glycopyrronium, neostigmine

EMA/471844/2016

1746

Glycopyrronium bromide (all indications except for chronic obstructive pulmonary disease): CMDh scientific conclusions and grounds for the variation, amendments to the product information, and timetable for the implement...,

glycopyrronium bromide

EMA/473578/2016

1745

Glibenclamide / metformin hydrochloride: List of nationally authorised medicinal products - PSUSA/00002002/201506,

glibenclamide, metformin hydrochloride

EMA/284356/2016

1744

Glibenclamide / metformin hydrochloride: CMDh scientific conclusions and grounds for the variation, amendments to the product information and timetable for the implementation - PSUSA/00002002/201506,

glibenclamide, metformin hydrochloride

EMA/284334/2016

1743

Tiludronic acid: List of nationally authorised medicinal products - PSUSA/00002959/201502,

tiludronic acid

EMA/650026/2015

1742

Glycopyrronium / neostigmine: CMDh Scientific conclusions and grounds for the variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001557/201509,

glycopyrronium, neostigmine

EMA/471859/2016

1741

Glatiramer: List of nationally authorised medicinal products - PSUSA/00001529/201411,

EMA/677092/2015

1740

Paracetamol (IV formulation): List of nationally authorised medicinal products - PSUSA/00002311/201505,

1739

(18f) Fludeoxyglucose: List of nationally authorised medicinal products - PSUSA/00001437/201411,

fludeoxyglucose (18F)

EMA/665781/2015

1738

5 Fluorouracil (topical application): CMDh scientific conclusions and grounds for variation, amendments to the product information and timetable for the implementation - PSUSA/00010000/201412,

EMA/757666/2015

1737

5 Fluorouracil (topical application): List of nationally authorised medicinal products - PSUSA/00010000/201412,

EMA/757684/2015

1736

5 Fluorouracil (i.v. application): List of nationally authorised medicinal products - PSUSA/00000007/201412,

EMA/706456/2015

1735

5 Fluorouracil, salicylic acid: List of nationally authorised medicinal products - PSUSA/00000008/201505,

5 fluorouracil, salicylic acid

最新招商产品更多>>

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441 QQ客服：

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

药药网药品采购交流

医药代理商群２：

药药网药品采购交流2

医药代理商群３：

药药网药品采购交流3